Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Three Amigos Stock Thread -- Ignore unavailable to you. Want to Upgrade?

To: rebecca who wrote (604)	2/13/1998 5:46:00 PM
From: Sergio H	Respond to of 29382

Rebeca, there was a nice discussion last night on this thread about ATCI from different perspectives. That's the way it should be done. Sergio

To: rebecca who wrote (604)	2/13/1998 9:34:00 PM
From: Sergio H	Read Replies (1) \| Respond to of 29382

Rebecca, Peg and Instock....congratulations are in order. Nice play on ATCI. Rebecca's e-mail to me asked about royalties etc. I thought I would post what I found here for anyone else that might be interested. Also noteworthy is that CIBA Vision Group owns a substantial percentage of ATCI with rights to acquire more shares in 1999. CIBA is a subsidiary of Novartis, which suprisingly trades as a BB here in the US (NVTSY) From company fillings: The Strategic Alliance Agreement provides that the Company shall pay commissions to CIBA on all ophthalmic refractive laser equipment revenues, including patient procedures fees, net of royalties to IBM, Pillar Point Partners, Summit and VISX, in the amount of 6% of such revenues. The CIBA commissions are limited to an aggregate of $10,000,000 unless the Company chooses to continue paying such commissions for five additional years in lieu of issuing a certain number of its shares of Common Stock to CIBA. The agreement may be terminated by CIBA under certain circumstances.